Zobrazeno 1 - 10
of 272
pro vyhledávání: '"G Hanania"'
Autor:
X. Marcaggi, J. Taeib, Michel Hanssen, J.-L. Hirsch, F. Albert, C. Charbonnel, M. Ross, Loic Belle, A. Dellinger, Simon Cattan, M. Steinbach, J.-L. Georges, Bernard Livarek, G. Hanania, N. Ferrier, Jean-Pierre Monassier, P. Jourdain, Walid Amara, F. Fellinger, M. Pansieri, D Pesenti Possi, Jacques Monsegu, Jean-Jacques Dujardin, Alain Dibie, F. Georger, H. Horeman, Khalife Khalife
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 61:307-310
Autor:
G. Hanania, J.P. Maroni
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 54:339-343
The continuous prolongation of life expectancy in developed nations and the progress made in the surgical treatment of valvulopathy have substantially increased the number of octogenarians undergoing heart valve surgery with extracorporeal circulatio
Autor:
Leon J. Bodzin, Bernhard O. Palsson, Janine Stevens, Manfred R. Koller, Annabeth Fieck, Elie G. Hanania
Publikováno v:
Biotechnology and Bioengineering. 91:872-876
Cloning of highly-secreting recombinant cells is critical for biopharmaceutical manufacturing, but faces numerous challenges including the fact that secreted protein does not remain associated with the producing cell. A fundamentally new approach was
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 52:290-296
Prosthetic valve replacement has transformed the outcome of patients with severe or poorly tolerated valvular heart disease. Between the two main families of prostheses, only mechanical prostheses require indefinite anticoagulant therapy to lower the
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 51:268-274
Resume Le recours tres large aux procedures chirurgicales interventionnelles de revascularisation a transforme le pronostic et l’evolution des cardiopathies ischemiques. Pontage et angioplastie coronaires n’ont cependant pas fait disparaitre les
Autor:
L J Murray, Beth L Hill, Marilyn Travis, Ivan Plavec, E. G. Hanania, Katherine Olsson, Karin Luens-Abitorabi, Sean P. Forestell
Publikováno v:
Human Gene Therapy. 11:2039-2050
Absence of durable high-level expression of transgenes from Moloney murine leukemia (Mo-MuLV) retroviral vectors has been a hurdle in bringing effective gene therapy to the clinic. In this study we have analyzed transgene expression among the progeny
Autor:
Philippe Mazars, Mauricette Michallet, Gilles Salles, Anne Thiebaut, Denis Fiere, Tom Leemhuis, Kerry Atkinson, Eric Archimbaud, Hubert Godinot, Christopher L. Reading, Francis Lopez, Gilbert Fine, Bertrand Coiffier, Catherine Sebban, Chris Juttner, Pierre Biron, Nora Roubi, Irène Philip, E. G. Hanania, Thierry Philip
Publikováno v:
Experimental Hematology. 28:858-870
Objective The aims of our study performed in myeloma were to evaluate the performance and the safety of Systemix's high-speed clinical cell sorter, to assess the safety and efficacy of de-escalating cell dose cohorts of CD34 + Thy1 + hematopoietic st
Publikováno v:
Leukemia. 13:1833-1842
Non-Hodgkin's lymphoma (NHL) arises as a clonal transformation of normal B and T cell differentiation and is often characterized by a higher incidence of specific chromosomal translocations. We have developed real-time TaqMan PCR assays directed towa
Autor:
Deborah Ellerson, Richard E. Giles, Richard E. Champlin, Michael Andreeff, Fernando Cabanillas, Shelly Heimfeld, Albert B. Deisseroth, F. Garcia-Sanchez, Raja Choudhury, Ellie G. Hanania, Carlos Bachier, Ronald J. Berenson
Publikováno v:
Scopus-Elsevier
We conducted a double retroviral vector (RV) gene marking trial to test for the possible contribution to relapse of follicular non-Hodgkin's lymphoma (FNHL) cells present in bone marrow (BM) and peripheral blood (PB) grafts used for hematopoietic rec
Autor:
Z. Zu, Ronald J. Berenson, Robert C. Bast, R. E. Giles, Debra Ellerson, Gabriel N. Hortobagyi, Peter F. Thall, Michael Andreeff, D. Seong, R. E. Bird, Richard E. Champlin, Tong Wang, Creighton L. Edwards, John J. Kavanagh, Jeane P. Hester, Shelly Heimfeld, Martin Korbling, T. Holzmayer, Y. Su, A. Chang, Barbara Burtness, Richard J. Cote, E. G. Hanania, Andrzej P. Kudelka, Carlos Bachier, Frankie A. Holmes, Eugene Mechetner, Z. Rahman, Su Chun Cheng, J. M. Ostrove, David F. Claxton, Albert B. Deisseroth
Publikováno v:
Proceedings of the National Academy of Sciences. 93:15346-15351
To formally test the hypothesis that the granulocyte/macrophage colony-forming unit (GM-CFU) cells can contribute to early hematopoietic reconstitution immediately after transplant, the frequency of genetically modified GM-CFU after retroviral vector